Understand the source comparison
Peptides vs Standard Ulcer Treatments: Therapeutic Positioning
Peptides don't replace proton pump inhibitors (PPIs) or H. pylori eradication protocols. They augment them. PPIs reduce gastric acid secretion, creating an environment where healing can occur. Peptides accelerate the repair process itself. A 2022 comparative s
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Peptides don't replace proton pump inhibitors (PPIs) or H. pylori eradication protocols. They augment them. PPIs reduce gastric acid secretion, creating an environment where healing can occur. Peptides accelerate the repair process itself. A 2022 comparative study found that combining BPC-157 with omeprazole reduced healing time to 9.2 days versus 16.4 days with omeprazole alone.
- The critical difference is mechanism of action. PPIs suppress acid production by blocking H+/K+ ATPase pumps in parietal cells. This reduces further mucosal damage but doesn't stimulate tissue regeneration. Growth factor-mimetic peptides directly activate cellular proliferation and angiogenesis pathways. Producing measurable increases in granulation tissue formation and epithelial coverage.
- NSAID-induced ulcers present a specific challenge because NSAIDs inhibit cyclooxygenase enzymes (COX-1, COX-2), reducing prostaglandin synthesis. Prostaglandins normally protect gastric mucosa by increasing mucus and bicarbonate secretion. Peptides bypass this pathway entirely by activating VEGF and EGF receptors independent of prostaglandin signaling. Research shows BPC-157 maintains gastric protection even when COX inhibition continues.